Loading…
History from 2026-05-27 to 2026-07-09. Every number below is a fact from TED/TenderNed notices — who this buyer awards to, what it buys, and what is open right now.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| IPSEN PHARMA, S.A. | 1 | €269k | 2026-07-09 |
| NOVO NORDISK PHARMA SA | 1 | €186k | 2026-05-27 |
| NOVARTIS FARMACEUTICA, SA | 1 | €170k | 2026-06-26 |
| Category | Notices | Open | Latest |
|---|---|---|---|
33 Medical equipment & pharmaceuticals | 3 | 0 | 2026-07-09 |
Recurring categories with no open notice are re-tender candidates — this buyer has bought them before and will again.
| Published | Title | Outcome | Awarded |
|---|---|---|---|
| 2026-07-09 | El contrato tiene por objeto dar respuesta a las necesidades asistenciales de la Gerencia de Servicios Sanitarios del Área deSalud de Fuerteventura en cuanto al suministro farmacéutico del principio activo Cabozantinib | won by IPSEN PHARMA, S.A. | €268,831 |
| 2026-06-26 | Suministro farmacéutico del principio activo Asciminib 40 mg y Asciminib 20 mg. | won by NOVARTIS FARMACEUTICA, SA | €169,630 |
| 2026-05-27 | Suministro del principio activo EPTACOG ALFA | won by NOVO NORDISK PHARMA SA | €185,983 |